Study #2023-0365
Targeted therapy to increase RAI uptake in patients with metastatic differentiated thyroid Cancer
MD Anderson Study Status
Enrolling
Treatment Agent
Description
Papillary thyroid cancer (PTC) is a common type of differentiated thyroid cancer (DTC) in children and represents the second most common cancer in adolescent females. Recently targeted drugs that block many of the genetic drivers of DTC have become available. While Investigators know that these drugs shrink DTC tumors in many cases, the impact on radioactive iodine (RAI) avidity has not been systematically studied.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Papillary Thyroid Cancer;Pediatric Cancer;Differentiated Thyroid Cancer
Study phase:
Physician name:
Steven Waguespack
Department:
Endocrine Neoplasia and HD
For general questions about clinical trials:
1-877-632-6789
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.